Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Alligator Bioscience

0.20 SEK

-1.81 %

Less than 1K followers

ATORX

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Alligator Bioscience

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue1.441.857.80.50.10.5
EBITDA-59.9-18.3-180.4-42.6-10.4-17.0
EBIT-62.0-60.1-229.1-43.7-22.3-17.3-22.6-105.8
EBIT-%-4,338.5 %-143.8 %-396.6 %-3,695.1 %-45,100.0 %-20,588.7 %
Profit before taxes-66.5-55.4-233.9-8.4-1.7-12.3-29.1-51.4
Net income-66.5-55.4-233.9-8.4-1.7-12.3-29.1-51.4
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.